In LUAC (Lung adenocarcinoma), the carcinogenic KRAS mutation leads to the loss of STK11(LKB1), thereby recruiting neutrophils with T‐cell inhibitory effects, resulting in reduced T‐cell infiltration. This evidence concerns the gene STK11 and lung adenocarcinoma.